Valuation: Avantor, Inc.

Market Cap 978.01Cr 837.77Cr 783.88Cr 717.55Cr 1.35TCr 94TCr 1.36TCr 9.26TCr 3.61TCr 47TCr 3.67TCr 3.59TCr 1,55500Cr P/E 2026 *
43.3x
P/E 2027 * 31x
Enterprise Value 1.29TCr 1.1TCr 1.03TCr 942.97Cr 1.77TCr 1,23000Cr 1.79TCr 12TCr 4.75TCr 62TCr 4.83TCr 4.72TCr 2,04300Cr EV / Sales 2026 *
1.95x
EV / Sales 2027 * 1.81x
Free-Float
95.49%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 18/08/2025
Director of Finance/CFO 50 24/06/2026
Chief Operating Officer - 10/11/2025
Director TitleAgeSince
Director/Board Member 60 22/04/2020
Chairman 69 01/01/2026
Director/Board Member 62 01/10/2021
Date Insider Type Main position Quantity % Market Cap.
18/08/26 Tax

Chief Executive Officer

-29,803 0.0044%
14/08/26 Tax

Head of Human Resources

-181 0.0000%
31/07/26 Tax

Chief Financial Officer

-1,385 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.47%+5.86% - - 978.01Cr
+2.19%+4.84%-12.03%+10.93% 20TCr
+1.14%+2.28%+0.69%+11.50% 12TCr
+1.06%+1.34%+8.69%+78.71% 6.07TCr
-1.37%-6.57%+30.31%+55.01% 5.24TCr
+2.33%+4.69%-3.84%-30.36% 5.23TCr
+2.35%+2.89%+12.25%-13.68% 3.48TCr
+5.16%-4.14% - - 3.01TCr
-0.20%+1.05%+42.46%-10.20% 2.48TCr
-0.29%-3.87%-6.19%+25.59% 2.38TCr
Average +1.38%+0.84%+9.04%+15.94% 6.1TCr
Weighted average by Cap. +1.53%+1.97%+1.58%+16.71%

Financials

2026 *2027 *
Net sales 659.37Cr 564.82Cr 528.48Cr 483.77Cr 907.89Cr 63TCr 919.89Cr 6.24TCr 2.43TCr 32TCr 2.48TCr 2.42TCr 1,04800Cr 674.97Cr 578.18Cr 540.99Cr 495.21Cr 929.38Cr 65TCr 941.65Cr 6.39TCr 2.49TCr 32TCr 2.53TCr 2.48TCr 1,07300Cr
Net income 23Cr 19Cr 18Cr 17Cr 31Cr 2.15TCr 31Cr 213.19Cr 83Cr 1.08TCr 85Cr 83Cr 3.58TCr 31Cr 27Cr 25Cr 23Cr 43Cr 2.97TCr 43Cr 294.29Cr 114.76Cr 1.49TCr 116.69Cr 114.16Cr 4.94TCr
Net Debt 307.24Cr 263.18Cr 246.25Cr 225.42Cr 423.04Cr 29TCr 428.63Cr 2.91TCr 1.13TCr 15TCr 1.15TCr 1.13TCr 49TCr 244.13Cr 209.12Cr 195.67Cr 179.11Cr 336.14Cr 23TCr 340.58Cr 2.31TCr 901.52Cr 12TCr 916.68Cr 896.73Cr 39TCr
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company's segments include Bioscience & Medtech Products and VWR Distribution & Services. Through these segments, it provides materials and consumables, equipment and instrumentation and services and specialty procurement to customers in biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and others.
Employees
13,500
Date Price Change Volume
21/26/21 $14.46 +1.47% 60,63,680
20/26/20 $14.25 +2.08% 71,30,643
19/26/19 $13.96 +4.73% 64,21,212
18/26/18 $13.33 -1.26% 63,10,268
17/26/17 $13.50 -1.17% 45,37,083
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
14.46USD
Average target price
14.56USD
Spread / Average Target
+0.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AVTR Stock